It is unknown whether OZEMPIC causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans as the human relevance of semaglutide-induced rodent thyroid C-cell tumors has not been determined (5.1, 13.1)
Yasui-Furukori, N., Hidestrand, M., Spina, E., Facciol, G., Scordo, M
Semaglutide FAQs What happens if I miss a dose
By activating GLP-1 receptors, Ozempic slows down gastric emptying (the rate at which food leaves the stomach), leading to increased feelings of fullness and reduced hunger
b Key inclusion criteria for the STEP 2 trial were age 18 years, type 2 diabetes diagnosed 180 days prior, BMI 27 kg/m 2 , HbA 1c 7%10% (5386 mmol/mol) and treatment with diet and exercise alone or stable treatment with metformin, sulphonylurea, sodiumglucose cotransporter2 inhibitor, glitazone as singleagent therapy or 3 agents for diabetes according to local label